Clement C Zai1, Vanessa F Gonçalves1, Arun K Tiwari2, Sarah A Gagliano3, Georgina Hosang4, Vincenzo de Luca5, Sajid A Shaikh2, Nicole King2, Qian Chen6, Wei Xu7, John Strauss2, Gerome Breen8, Cathryn M Lewis8, Anne E Farmer8, Peter McGuffin8, Jo Knight5, John B Vincent9, James L Kennedy10. 1. Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. 2. Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. 3. Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Ontario, Canada. 4. Department of Psychology, Goldsmiths, University of London, New Cross, London, United Kingdom; MRC Social, Genetic & Developmental Psychiatry Centre, King's College London, London, United Kingdom. 5. Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Ontario, Canada. 6. Cancer Care Ontario, Toronto, Ontario, Canada. 7. Dalla Lana School of Public Health, University of Toronto, Ontario, Canada; Ontario Cancer Institute, Prince Margaret Hospital, Toronto, Ontario, Canada. 8. MRC Social, Genetic & Developmental Psychiatry Centre, King's College London, London, United Kingdom. 9. Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Ontario, Canada; Molecular Neuropsychiatry and Development Laboratory (MiND), Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. 10. Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Ontario, Canada. Electronic address: jim.kennedy@camh.ca.
Abstract
BACKGROUND: Suicide claims one million lives worldwide annually, making it a serious public health concern. The risk for suicidal behaviour can be partly explained by genetic factors, as suggested by twin and family studies (reviewed in (Zai et al. 2012)). Recently, genome-wide association studies (GWASs) of suicide attempt on large samples of bipolar disorder (BD) patients from multiple sites have identified a number of novel candidate genes. GWASs of suicide behaviour severity, from suicidal ideation to serious suicide attempt, have not been reported for BD. METHODS: We conducted a GWAS of suicide behaviour severity in three independent BD samples:212 small nuclear families with BD probands from Toronto, Canada, 428 BD cases from Toronto, and 483 BD cases from the UK. We carried out imputation with 1000 Genome Project data as reference using IMPUTE2. Quality control and data analysis was conducted using PLINK and R. We conducted the quantitative analyses of suicide behaviour severity in the three samples separately, and derived an overall significance by a meta-analysis using the METAL software. RESULTS: We did not find genome-wide significant association of any tested markers in any of the BD samples, but we found a number of suggestive associations, including regions on chromosomes 8 and 10 (p < 1e-5). CONCLUSIONS: Our GWAS findings suggest that likely many gene variants of small effects contribute collectively to the risk for suicidal behaviour severity in BD. Larger independent replications are required to strengthen the findings from the GWAS presented here.
BACKGROUND: Suicide claims one million lives worldwide annually, making it a serious public health concern. The risk for suicidal behaviour can be partly explained by genetic factors, as suggested by twin and family studies (reviewed in (Zai et al. 2012)). Recently, genome-wide association studies (GWASs) of suicide attempt on large samples of bipolar disorder (BD) patients from multiple sites have identified a number of novel candidate genes. GWASs of suicide behaviour severity, from suicidal ideation to serious suicide attempt, have not been reported for BD. METHODS: We conducted a GWAS of suicide behaviour severity in three independent BD samples:212 small nuclear families with BD probands from Toronto, Canada, 428 BD cases from Toronto, and 483 BD cases from the UK. We carried out imputation with 1000 Genome Project data as reference using IMPUTE2. Quality control and data analysis was conducted using PLINK and R. We conducted the quantitative analyses of suicide behaviour severity in the three samples separately, and derived an overall significance by a meta-analysis using the METAL software. RESULTS: We did not find genome-wide significant association of any tested markers in any of the BD samples, but we found a number of suggestive associations, including regions on chromosomes 8 and 10 (p < 1e-5). CONCLUSIONS: Our GWAS findings suggest that likely many gene variants of small effects contribute collectively to the risk for suicidal behaviour severity in BD. Larger independent replications are required to strengthen the findings from the GWAS presented here.
Authors: Eric T Monson; Mehdi Pirooznia; Jennifer Parla; Melissa Kramer; Fernando S Goes; Marie E Gaine; Sophia C Gaynor; Kelly de Klerk; Dubravka Jancic; Rachel Karchin; W Richard McCombie; Peter P Zandi; James B Potash; Virginia L Willour Journal: Mol Neuropsychiatry Date: 2017-01-18
Authors: Qingqin S Li; Andrey A Shabalin; Emily DiBlasi; Srihari Gopal; Carla M Canuso; Aarno Palotie; Wayne C Drevets; Anna R Docherty; Hilary Coon Journal: Mol Psychiatry Date: 2022-10-17 Impact factor: 13.437
Authors: Rona J Strawbridge; Joey Ward; Amy Ferguson; Nicholas Graham; Richard J Shaw; Breda Cullen; Robert Pearsall; Laura M Lyall; Keira J A Johnston; Claire L Niedzwiedz; Jill P Pell; Daniel Mackay; Julie Langan Martin; Donald M Lyall; Mark E S Bailey; Daniel J Smith Journal: EBioMedicine Date: 2019-02-08 Impact factor: 8.143
Authors: Sophia C Gaynor; Eric T Monson; Marie E Gaine; Michael S Chimenti; Rachel D Reichman; Meredith Parsons; Lalita Oonthonpan; Peter P Zandi; James B Potash; Virginia L Willour Journal: J Psychiatr Res Date: 2019-11-18 Impact factor: 4.791
Authors: Annette Erlangsen; Vivek Appadurai; Yunpeng Wang; Gustavo Turecki; Ole Mors; Thomas Werge; Preben B Mortensen; Anna Starnawska; Anders D Børglum; Andrew Schork; Ron Nudel; Marie Bækvad-Hansen; Jonas Bybjerg-Grauholm; David M Hougaard; Wesley K Thompson; Merete Nordentoft; Esben Agerbo Journal: Mol Psychiatry Date: 2018-08-16 Impact factor: 15.992
Authors: Marie E Breen; Sophia C Gaynor; Eric T Monson; Kelly de Klerk; Meredith G Parsons; Terry A Braun; Adam P DeLuca; Peter P Zandi; James B Potash; Virginia L Willour Journal: PLoS One Date: 2016-12-28 Impact factor: 3.240
Authors: Clement C Zai; Arun K Tiwari; Gwyneth C Zai; Vincenzo de Luca; Sajid A Shaikh; Nicole King; John Strauss; James L Kennedy; John B Vincent Journal: Mol Neuropsychiatry Date: 2018-05-03